NDC 49288-0642
Post Oak
Post Oak
Post Oak is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Quercus Stellata Pollen.
| Product ID | 49288-0642_13c9eea1-38b5-472b-b735-a814ca886718 |
| NDC | 49288-0642 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Post Oak |
| Generic Name | Post Oak |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRADERMAL; SUBCUTANEOUS |
| Marketing Start Date | 1974-03-23 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102223 |
| Labeler Name | Antigen Laboratories, Inc. |
| Substance Name | QUERCUS STELLATA POLLEN |
| Active Ingredient Strength | 0 g/mL |
| Pharm Classes | Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
Packaging
NDC 49288-0642-4
30 mL in 1 VIAL, MULTI-DOSE (49288-0642-4)
| Marketing Start Date | 1974-03-23 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 49288-0642-4 [49288064204]
Post Oak INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
NDC 49288-0642-3 [49288064203]
Post Oak INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
NDC 49288-0642-5 [49288064205]
Post Oak INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
NDC 49288-0642-1 [49288064201]
Post Oak INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
NDC 49288-0642-2 [49288064202]
Post Oak INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| QUERCUS STELLATA POLLEN | .05 g/mL |
OpenFDA Data
Pharmacological Class
- Non-Standardized Pollen Allergenic Extract [EPC]
- Increased Histamine Release [PE]
- Cell-mediated Immunity [PE]
- Increased IgG Production [PE]
- Pollen [CS]
- Allergens [CS]
Trademark Results [Post Oak]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 POST OAK 97227969 not registered Live/Pending |
Avonak Distillery LLC 2022-01-19 |
 POST OAK 88282570 not registered Live/Pending |
JOHNSON STREET PARTNERS, LLC 2019-01-30 |
 POST OAK 86723021 not registered Dead/Abandoned |
Sherri Qualls 2015-08-12 |
 POST OAK 73574643 not registered Dead/Abandoned |
POST PROPERTIES, INC. 1985-12-23 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.